Glenmark Speclt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK SPECLT, and when can generic versions of GLENMARK SPECLT drugs launch?
GLENMARK SPECLT has twenty-seven approved drugs.
There are fourteen US patents protecting GLENMARK SPECLT drugs.
There are eighty patent family members on GLENMARK SPECLT drugs in thirty-two countries and ninety-one supplementary protection certificates in fifteen countries.
Summary for Glenmark Speclt
| International Patents: | 80 |
| US Patents: | 14 |
| Tradenames: | 23 |
| Ingredients: | 22 |
| NDAs: | 27 |
Drugs and US Patents for Glenmark Speclt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209433-002 | Jan 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | 10,765,686 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 208320-001 | Aug 22, 2017 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | 10,758,550 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Glenmark Speclt Drugs
Supplementary Protection Certificates for Glenmark Speclt Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0734381 | 04C0010 | France | ⤷ Sign Up | PRODUCT NAME: APREPITANT; REGISTRATION NO/DATE: EU/1/03/262/001 20031111 |
| 1586316 | SPC/GB11/054 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523 |
| 1380301 | CA 2009 00017 | Denmark | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
| 1214076 | C01214076/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
